Tumor markers

Results: 502



#Item
21I bodywise  much as $14 million among approximately 70 researchers.

I bodywise much as $14 million among approximately 70 researchers. "Some of the most recent research is the most exciting," says Lauder,

Add to Reading List

Source URL: amyblumenfeld.com

Language: English - Date: 2015-04-09 14:57:54
22Verification Bias and the Prostate-Specific Antigen Test

Verification Bias and the Prostate-Specific Antigen Test

Add to Reading List

Source URL: www.usrf.org

Language: English - Date: 2003-08-22 17:17:12
23Diagnosis  PSA Testing The key for early detection By Jason K. Spunger, M.D

Diagnosis PSA Testing The key for early detection By Jason K. Spunger, M.D

Add to Reading List

Source URL: www.urologyin.com

Language: English
24Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate cancer therapy. It is highly expresse

Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate cancer therapy. It is highly expresse

Add to Reading List

Source URL: www.campus-technologies.de

Language: English - Date: 2014-11-10 10:17:25
25The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer G. Theil 1, S. Schmidt 1, K. Fischer 1, K. Luecke, B 2. Nowack2, N. Mohammed

The isolation of prostate cancer specific circulating tumor cells in the blood of patients with metastatic castration-resistant prostate cancer G. Theil 1, S. Schmidt 1, K. Fischer 1, K. Luecke, B 2. Nowack2, N. Mohammed

Add to Reading List

Source URL: www.gilupi.de

Language: English - Date: 2014-05-27 05:36:39
26Microsoft Word - BRCA Share PREurope Version

Microsoft Word - BRCA Share PREurope Version

Add to Reading List

Source URL: www.inserm-transfert.fr

Language: English - Date: 2015-04-22 06:57:43
27ARIEL2: A phase 2 study to prospectively identify ovarian cancer patients likely to respond to rucaparib Elizabeth Swisher,1 James Brenton,2 Scott Kaufmann,3 Amit Oza,4 Robert L. Coleman,5 David O’Malley,6 Gottfried Ko

ARIEL2: A phase 2 study to prospectively identify ovarian cancer patients likely to respond to rucaparib Elizabeth Swisher,1 James Brenton,2 Scott Kaufmann,3 Amit Oza,4 Robert L. Coleman,5 David O’Malley,6 Gottfried Ko

Add to Reading List

Source URL: www.foundationmedicine.com

Language: English - Date: 2014-11-25 16:41:42
28Nationwide Study of Breast Cancer Risk Factors in Latinas Michael Dean, Latoya Silverton, Julie Sawitzke Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute

Nationwide Study of Breast Cancer Risk Factors in Latinas Michael Dean, Latoya Silverton, Julie Sawitzke Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute

Add to Reading List

Source URL: precedings.nature.com

Language: English
29MedicineToday  PEER REVIEWED ARTICLE Prostate cancer

MedicineToday PEER REVIEWED ARTICLE Prostate cancer

Add to Reading List

Source URL: www.prostate.com.au

Language: English - Date: 2007-01-01 20:57:21
30GeneDx 207 Perry Parkway Gaithersburg, MDPhone: Fax: E-mail:

GeneDx 207 Perry Parkway Gaithersburg, MDPhone: Fax: E-mail:

Add to Reading List

Source URL: www.genedx.com

Language: English - Date: 2015-05-14 13:07:11